January 16, 2020
Yukio Ando, Vice President, Nagasaki International University The pharmaceutical industry has witnessed an increasing number of oligonucleotide therapeutic launches in recent years. For two, Spinraza (nusinersen) and Onpattro (patisiran), rolled out in 2017 and 2019, became game changers in the...read more